Large intergenic non-coding RNA-ROR reverses Gemcitabine-induced autophagy and apoptosis in breast cancer cells

被引:46
作者
Chen, Yao-Min [1 ]
Liu, Yu [1 ]
Wei, Hai-Yan [1 ]
Lv, Ke-Zhen [1 ]
Fu, Pei-Fen [1 ]
机构
[1] Zhejiang Univ, Dept Breast Surg, Affiliated Hosp 1, Hangzhou 310000, Zhejiang, Peoples R China
关键词
breast cancer; linc-ROR; gemcitabine; large intergenic non-coding; PANCREATIC-CANCER; GENE-EXPRESSION; STEM-CELLS; THERAPY; PATHWAY; DIFFERENTIATION; CONTRIBUTES; BEVACIZUMAB; METASTASIS; INHIBITION;
D O I
10.18632/oncotarget.10730
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this study was to elucidate the potential role of long intergenic non-protein coding RNA, regulator of reprogramming (linc-ROR) in gemcitabine (Gem)-induced autophagy and apoptosis in breast cancer cells. MDA-MB-231 cells were treated with short hairpin RNA (shRNA) to knockdown Linc-ROR expression in the presence of Gem. Gem treatment alone decreased cell survival and increased both apoptosis and autophagy. Gem treatment also increased the expression of LC3-II, Beclin 1, NOTCH1 and Bcl-2, but decreased expression of p62 and p53. Untreated MDA-MB-231 cell lines strongly expressed linc-ROR, but linc-ROR knockdown decreased cell viability and expression of p62 and p53 while increasing apoptosis. Linc-ROR knockdown also increased LC3-II/beta-actin, Beclin 1, NOTCH1, and Bcl-2 expression, as well as the number of autophagic vesicles in MDA-MB-231 cells. Linc-ROR negatively regulated miR-34a expression by inhibiting histone H3 acetylation in the miR-34a promoter. We conclude that linc-ROR suppresses Gem-induced autophagy and apoptosis in breast cancer cells by silencing miR-34a expression.
引用
收藏
页码:59604 / 59617
页数:14
相关论文
共 54 条
  • [1] Amaral JD, 2010, DISCOV MED, V9, P145
  • [2] [Anonymous], TUMOUR BIOL
  • [3] Askarian-Amiri ME, 2016, METHODS MOL BIOL, V1395, P207, DOI 10.1007/978-1-4939-3347-1_12
  • [4] p53-dependent Induction of PVT1 and miR-1204
    Barsotti, Anthony M.
    Beckerman, Rachel
    Laptenko, Oleg
    Huppi, Konrad
    Caplen, Natasha J.
    Prives, Carol
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (04) : 2509 - 2519
  • [5] Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer
    Bear, Harry D.
    Tang, Gong
    Rastogi, Priya
    Geyer, Charles E., Jr.
    Robidoux, Andre
    Atkins, James N.
    Baez-Diaz, Luis
    Brufsky, Adam M.
    Mehta, Rita S.
    Fehrenbacher, Louis
    Young, James A.
    Senecal, Francis M.
    Gaur, Rakesh
    Margolese, Richard G.
    Adams, Paul T.
    Gross, Howard M.
    Costantino, Joseph P.
    Swain, Sandra M.
    Mamounas, Eleftherios P.
    Wolmark, Norman
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (04) : 310 - 320
  • [6] Benson JR, 2012, FUTURE ONCOL, V8, P697, DOI [10.2217/fon.12.61, 10.2217/FON.12.61]
  • [7] Defining the membrane precursor supporting the nucleation of the phagophore
    Bernard, Amelie
    Klionsky, Daniel J.
    [J]. AUTOPHAGY, 2014, 10 (01) : 1 - 2
  • [8] Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
    Chang, Tsung-Cheng
    Wentzel, Erik A.
    Kent, Oliver A.
    Ramachandran, Kalyani
    Mullendore, Michael
    Lee, Kwang Hyuck
    Feldmann, Georg
    Yamakuchi, Munekazu
    Ferlito, Marcella
    Lowenstein, Charles J.
    Arking, Dan E.
    Beer, Michael A.
    Maitra, Anirban
    Mendell, Joshua T.
    [J]. MOLECULAR CELL, 2007, 26 (05) : 745 - 752
  • [9] Regulation of the autophagy protein LC3 by phosphorylation
    Cherra, Salvatore J., III
    Kulich, Scott M.
    Uechi, Guy
    Balasubramani, Manimalha
    Mountzouris, John
    Day, Billy W.
    Chu, Charleen T.
    [J]. JOURNAL OF CELL BIOLOGY, 2010, 190 (04) : 533 - 539
  • [10] ROS-mediated mechanisms of autophagy stimulation and their relevance in cancer therapy
    Dewaele, Michael
    Maes, Hannelore
    Agostinis, Patrizia
    [J]. AUTOPHAGY, 2010, 6 (07) : 838 - 854